JP2023524102A5 - - Google Patents
Info
- Publication number
- JP2023524102A5 JP2023524102A5 JP2022566628A JP2022566628A JP2023524102A5 JP 2023524102 A5 JP2023524102 A5 JP 2023524102A5 JP 2022566628 A JP2022566628 A JP 2022566628A JP 2022566628 A JP2022566628 A JP 2022566628A JP 2023524102 A5 JP2023524102 A5 JP 2023524102A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- abcb5
- cdr2
- cdr3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063018440P | 2020-04-30 | 2020-04-30 | |
| US63/018,440 | 2020-04-30 | ||
| PCT/US2021/030342 WO2021222861A1 (en) | 2020-04-30 | 2021-04-30 | Antibodies specific to abcb5 and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023524102A JP2023524102A (ja) | 2023-06-08 |
| JP2023524102A5 true JP2023524102A5 (cg-RX-API-DMAC7.html) | 2024-05-13 |
Family
ID=78373989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022566628A Pending JP2023524102A (ja) | 2020-04-30 | 2021-04-30 | Abcb5に特異的な抗体およびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230203153A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4142793A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023524102A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230034944A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116096753A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021262864A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3181591A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021222861A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3097875A1 (en) | 2018-04-25 | 2019-10-31 | Children's Medical Center Corporation | Abcb5 ligands and substrates |
| JP7137696B2 (ja) | 2019-05-14 | 2022-09-14 | プロヴェンション・バイオ・インコーポレイテッド | 1型糖尿病を予防するための方法および組成物 |
| CN114828861A (zh) * | 2019-10-10 | 2022-07-29 | 亚利桑那州立大学董事会 | 表达多特异性免疫细胞接合器的溶瘤病毒 |
| KR20230092863A (ko) | 2020-06-11 | 2023-06-26 | 프로벤션 바이오, 인코포레이티드 | 제1형 당뇨병을 예방하기 위한 방법 및 조성물 |
| KR20240004937A (ko) | 2021-05-05 | 2024-01-11 | 이매틱스 바이오테크놀로지스 게엠베하 | Bma031 항원 결합 폴리펩타이드 |
| MX2023013851A (es) | 2021-05-24 | 2023-12-08 | Provention Bio Inc | Metodos para el tratamiento de diabetes tipo 1. |
| JPWO2025004683A1 (cg-RX-API-DMAC7.html) * | 2023-06-30 | 2025-01-02 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2411101C (en) * | 2000-06-05 | 2018-01-16 | Brigham And Women's Hospital, Inc. | A gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof |
| PL2155248T3 (pl) * | 2007-04-12 | 2015-12-31 | Brigham & Womens Hospital Inc | Celowanie w ABCB5 w terapii nowotworowej |
| WO2010065711A1 (en) * | 2008-12-04 | 2010-06-10 | Adimab, Inc. | An abcb5 epitope and antibodies thereto for the treatment of cancer |
| US20180134771A1 (en) * | 2015-05-07 | 2018-05-17 | Bioxcel Corporation | Novel immunomodulatory therapeutic strategies targeting tumors in cancer |
| JP7849972B2 (ja) * | 2019-03-28 | 2026-04-22 | ザ チルドレンズ メディカル センター コーポレーション | 高機能な製造されたabcb5+間葉系幹細胞 |
-
2021
- 2021-04-30 JP JP2022566628A patent/JP2023524102A/ja active Pending
- 2021-04-30 KR KR1020227042053A patent/KR20230034944A/ko active Pending
- 2021-04-30 EP EP21796792.6A patent/EP4142793A4/en active Pending
- 2021-04-30 WO PCT/US2021/030342 patent/WO2021222861A1/en not_active Ceased
- 2021-04-30 AU AU2021262864A patent/AU2021262864A1/en active Pending
- 2021-04-30 CA CA3181591A patent/CA3181591A1/en active Pending
- 2021-04-30 US US17/922,286 patent/US20230203153A1/en active Pending
- 2021-04-30 CN CN202180046044.6A patent/CN116096753A/zh active Pending